Levofloxacin Market forecast to reach $1.9 Billion by 2025


Posted August 11, 2020 by Blessy_Joy

The mechanism of levofloxacin and other fluoroquinolone antimicrobials involves inhibition of bacterial topoisomerase IV and DNA gyrase. It is an injectable drug and is also marketed in tablet form.

 
Levofloxacin Market  is forecast to reach $1.9 Billion  by 2025, growing at a CAGR of 4.7% during the forecast period 2020-2025. Levofloxacin is an antibiotic marketed with a brand name Levaquin used for the destruction of bacteria inside the body. The mechanism of levofloxacin and other fluoroquinolone antimicrobials involves inhibition of bacterial topoisomerase IV and DNA gyrase. It is an injectable drug and is also marketed in tablet form. This drug is used for the diagnosis of pneumonia, acute bacterial sinusitis, chronic prostatitis, urinary tract infection and others. It is indicated for inhalational anthrax (post-exposure) to reduce the incidence or progression of disease exposure to aerosolized Bacillus anthracis. Budesonide and fluticasone are the replacement of levofloxacin drug. 

Key Takeaways
Rising government initiatives with an objective of improving awareness about diagnosis and treatment of pneumonia and similar infections is expected to aid growth of the market. 
Rising number of hospitals and retail pharmacies are set to aid the growth of levofloxacin market.
APAC region is estimated to record the fastest growth rate during the forecast period 2020-2025.

Download Sample Report @ https://www.industryarc.com/pdfdownload.php?id=501909

Geography - Segment Analysis
 
Based on the geography the Levofloxacin market is covered globally viz North America, South America, Europe, Asia Pacific (APAC) and Rest of World (ROW). Market in North America accounts for major share of 44% in terms of revenue and is projected to maintain its position over the forecast period 2020-2025. Rising number of government initiatives with an objective of improving awareness about diagnosis. Asia Pacific market in estimated to register highest CAGR in terms of revenue over the forecast period 2020-2025, owing to the major expansion in manufacturing pharmacies.


Market Drivers – Levofloxacin Market
Growing Incidences of Bacterial Infections
The growth of bacteria inside the body is affecting organs with body like infections related to sinuses, skin, lungs, ears, airways, bones, and others. The growth of urinary infection is increasing which is leading the growth of the market.


Levofloxacin industry outlook : Levofloxacin top 10 companies include Aden Healthcare, Allenge India Pharma, Alna Biotech Private Limited, Bestochem, Divine Savior Healthcare, Dr Reddys Laboratory Ltd, Glenmark Pharmaceutical, Lupin Pharmaceuticals, Inc, Pax Healthcare, Zydus Cadila. 

About IndustryARC :

IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications market research. Our Custom Research Services are designed to provide insights on the constant flux in the global supply-demand gap of markets. Our strong team of analysts enables us to meet the client research needs at a rapid speed, with a variety of options for your business. Any other custom requirements can be discussed with our team, drop an e-mail to [email protected] to discuss more about our consulting services.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Blessy
Business Address Madhapur
Country India
Categories Business
Tags levofloxacin market , levofloxacin market growth , levofloxacin market research , levofloxacin market share , levofloxacin market size
Last Updated August 11, 2020